Skip to main content

Table 2 Evaluation of the impact of MHR on ischemic stroke by multivariate logistic regression models

From: Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: insights from a population-based Chinese cohort

Variables

Odds Ratio (95% CI)

Crude

P value

Model 1

P value

Model 2

P value

MHR (Per 1 SD increase)

1.426 (1.221, 1.666)

<0.001

1.375 (1.170, 1.615)

<0.001

1.276 (1.082, 1.504)

0.004

Quartiles of MHR

 Quartile 1

1.000 (reference)

 

1.000 (reference)

 

1.000 (reference)

 

 Quartile 2

1.314 (0.831, 2.076)

0.243

1.206 (0.756, 1.925)

0.432

1.155 (0.720, 1.851)

0.550

 Quartile 3

1.434 (0.915, 2.248)

0.116

1.393 (0.880, 2.207)

0.157

1.257 (0.788, 2.005)

0.338

 Quartile 4

2.186 (1.440, 3.319)

<0.001

1.924 (1.252, 2.956)

0.003

1.624 (1.045, 2.524)

0.031

 P for trend

 

<0.001

 

0.001

 

0.024

  1. Abbreviations: MHR monocyte count to high-density lipoprotein cholesterol ratio, OR odds ratio; 95% CI: 95% confidence interval, SD standard deviation. Other abbreviations as in Table 1
  2. Crude: no adjustment; Model 1: adjusted for age, sex, race, education level, family annual income level, physical activity, current smoking, current drinking, and diet score; Model 2: adjusted for all the factors in model 1 and serum creatinine, systolic blood pressure, fasting plasma glucose, body mass index, and lipid-lowering drug
  3. Quartile 1: MHR < 0.229; Quartile 2: 0.229 ≤ MHR < 0.341; Quartile 3: 0.341 ≤ MHR < 0.485; Quartile 4: MHR ≥ 0.485